The Department of Defense, through the Defense Health Agency (DHA), intends to issue a sole source contract for the procurement of brand name Illumina reagents, kits, and consumables, specifically to Bio-Active Co., Ltd in Thailand. This procurement aims to support high-throughput sequencing workflows that are critical for microbial surveillance, viral detection, influenza typing, and gene expression profiling, utilizing products that are validated for compatibility with Illumina sequencing platforms. Interested parties are invited to respond within 15 days with evidence of their ability to provide comparable services; otherwise, the contract will be awarded solely to the identified vendor. For further inquiries, interested parties may contact John Fitzsimmons at john.l.fitzsimmons8.civ@health.mil or by phone at 301-514-2040.